MPWT
HBIO icon

MassMutual Private Wealth & Trust’s Harvard Bioscience HBIO Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-27
Closed -$572 – 2408
2024
Q4 		$572 Buy
+27
New +$620 ﹤0.01% 2121

Other funds holding HBIO

AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MassMutual Private Wealth & Trust's HBIO Position: Q1 2025 in Review

MassMutual Private Wealth & Trust sold out of Harvard Bioscience (HBIO) in Q1 2025, closing a stake of 27 shares — an estimated $572 sold.

MassMutual Private Wealth & Trust first reported a position in HBIO in Q4 2024 and held it in 1 quarter. The position peaked at $572 in Q4 2024. 91 funds tracked by Wall St. Rank hold HBIO as of Q1 2025.

  • MassMutual Private Wealth & Trust reported no remaining Harvard Bioscience position as of Q1 2025 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 27 Harvard Bioscience shares in Q1 2025, an estimated $572.
  • MassMutual Private Wealth & Trust first reported a position in Harvard Bioscience in Q4 2024 and held it in 1 quarter.
  • MassMutual Private Wealth & Trust's Harvard Bioscience position peaked at $572 in Q4 2024.
  • 91 funds tracked by Wall St. Rank held Harvard Bioscience as of Q1 2025.

Based on MassMutual Private Wealth & Trust's 13F filing for Q1 2025, filed 1 Apr 2025.